Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults.

Kemppinen, Anu; Howell, Carol; Allgar, Victoria; Dodd, Matthew; Gregson, John; Knowles, Charles; McLaughlin, John; Pandya, Preeti; Whorwell, Peter; Markaryan, Elena; +1 more... Yiannakou, Yan; (2020) Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults. TRIALS, 21 (1). p. 122. ISSN 1745-6215 DOI: https://doi.org/10.1186/s13063-020-4069-x

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1186/s13063-020-4069-x

Abstract

Item Type Article
Faculty and Department Faculty of Epidemiology and Population Health > Dept of Medical Statistics
PubMed ID 32000822
Elements ID 144751

Share

Download

Filename: Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosge.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar